✦ LIBER ✦

HDL and Cardiovascular-Disease Risk — Time for a New Approach?

✍ Scribed by Heinecke, Jay

Book ID: 111685260
Publisher: Massachusetts Medical Society
Year: 2011
Tongue: English
Weight: 441 KB
Volume: 364
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejme1012520

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crystal structure of CETP: new hopes for

Crystal structure of CETP: new hopes for raising HDL to decrease risk of cardiovascular disease?

✍ Hamilton, James A; Deckelbaum, Richard J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 603 KB

HDL Cognition and Dementia: Time for a N

HDL Cognition and Dementia: Time for a New Target?

✍ David T. Nash 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 47 KB

Chronic kidney disease: a new opportunit

Chronic kidney disease: a new opportunity for better cardiovascular risk stratification

✍ S. I. Hallan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Vagal nerve modulation: A promising new

Vagal nerve modulation: A promising new therapeutic approach for cardiovascular diseases

✍ Mei Zhao; Lei Sun; Jin-Jun Liu; Hao Wang; Yi Miao; Wei-Jin Zang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

PTSD is a risk factor for cardiovascular

PTSD is a risk factor for cardiovascular disease: Time for increased screening and clinical intervention

✍ Joseph A. Boscarino 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Glucose: a Continuous Risk Factor for Ca

Glucose: a Continuous Risk Factor for Cardiovascular Disease

✍ H.C. Gerstein 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

The glucose level that defines diabetes mellitus is that level above which patients have a high risk of eye, kidney, and neuronal disease. The risk of these complications rises as glucose levels increase, and decreases as therapy brings the glucose level down. Thus, in patients with diabetes, glucos